- $2.09bn
- $2.12bn
- $2.74bn
- 65
- 98
- 91
- 98
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Total Revenue | 983 | 890 | 2,130 | 2,106 | 2,737 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 759 | 715 | 2,095 | 2,556 | 2,320 |
Operating Profit | 224 | 175 | 35.1 | -450 | 418 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 201 | 152 | 45.1 | -423 | 319 |
Provision for Income Taxes | |||||
Net Income After Taxes | 201 | 144 | 55.8 | -386 | 364 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 201 | 144 | 58.1 | -387 | 355 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 200 | 142 | 44.6 | -403 | 339 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.16 | 1.53 | 0.079 | -2.51 | 2 |